OCHT Insider Trading Activity and SEC Form 4 Filings
OCHT insider trading summary
No open-market insider purchases or sales of Orchestra Therapeutics, Inc. (OCHT) have been reported on SEC Form 4 in the past 12 months.
Latest OCHT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 9, 2006 | Michael K Green | COO and CFO | Sell | $4.8M (2,474,900 @ $1.92) |
| Nov 8, 2006 | Michael K Green | COO and CFO | Sell | $3.4M (1,770,000 @ $1.90) |
| Nov 7, 2006 | Michael K Green | COO and CFO | Sell | $622K (325,600 @ $1.91) |
| Nov 6, 2006 | Michael K Green | COO and CFO | Sell | $302K (158,000 @ $1.91) |
| Nov 3, 2006 | Michael K Green | COO and CFO | Sell | $2.0M (1,042,500 @ $1.92) |
| Nov 2, 2006 | Michael K Green | COO and CFO | Sell | $2.0M (1,041,000 @ $1.96) |
| Nov 1, 2006 | Michael K Green | COO and CFO | Sell | $649K (333,000 @ $1.95) |
| Oct 31, 2006 | Michael K Green | COO and CFO | Sell | $706K (355,000 @ $1.99) |
| Oct 19, 2006 | Georgia Theofan | VP, Clinical Development | Sell | $1.4M (720,000 @ $2.00) |
| Sep 15, 2006 | Georgia Theofan | VP, Clinical Development | Sell | $300K (150,000 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.